Introduction
============

Research into nanotechnological approaches to infectious diseases is increasing rapidly,[@b1-ijn-10-1961] driven by the expectation that nanoparticles will be able to be used in the treatment of various diseases in the future.[@b2-ijn-10-1961]

Zinc oxide nanoparticles (ZNPs) represent one such nanotechnological approach, and are characterized by their high catalytic efficiency and high adsorbing ability.[@b3-ijn-10-1961] Moreover, zinc is considered to be an essential trace element for various cellular activities[@b4-ijn-10-1961] and is a part of more than 200 enzymes.[@b5-ijn-10-1961] Recently, Ahmadi et al[@b6-ijn-10-1961] reported that dietary ZNPs improved oxidant state and had positive effect on the activity of several serum enzymes. ZNPs have also been reported to have antimicrobial activities.[@b7-ijn-10-1961] In addition, Nadhman et al[@b8-ijn-10-1961] used ZNPs as novel photosensitizers for photodynamic therapy against *Leishmania*.

Coccidiosis is a widespread disease affecting many vertebrates worldwide. It is caused by the unicellular eukaryote *Eimeria*, which exhibits approximately 800 different species.[@b9-ijn-10-1961] The most dangerous of these is *Eimeria tenella*, which causes significant economic losses in poultry farms. The current study was designed to investigate both the anticoccidial activity and the antioxidant role of ZNPs, using the murine *Eimeria papillata* as a model parasite for coccidiosis.

Material and methods
====================

Synthesis of spherically shaped ZNPs
------------------------------------

The synthesis of ZNPs was performed by using zinc acetate dihydrate (Zn(CH~3~COO)~2~·2H~2~O) and octadecylamine (CH~3~(CH~2~)~17~NH~2~) as the source materials. In a typical experiment, zinc acetate dihydrate (0.1 M) was dissolved in 100 mL methanol with octadecylamine (0.05 M) under constant stirring (30 minutes) until it had completely dissolved. The zinc acetate dihydrate and octadecylamine were purchased from Sigma-Aldrich Corp (St Louis, MO, USA) and used without further purification. The obtained pH of the solution reached up to \~12.5. After the complete dissolution, the mixture was transferred to a refluxing pot and was refluxed at \~65°C for 6 hours. Initially, no precipitate was formed in the refluxing pot, but as the refluxing time increased, small molecules of white precipitate were set at the bottom of the refluxing pot. After cooling the refluxing pot to room temperature, the white precipitate was transferred to a glass beaker and washed with methanol, ethanol, and acetone several times to remove any ionic impurities. The sample was then dried in a glass Petri dish at room temperature and was examined for its morphological and chemical properties.

Characterization of ZNPs
------------------------

The morphology of the obtained white powder sample was characterized by using field emission scanning electron microscopy (FESEM), while the crystalline properties were examined by X-ray diffraction (XRD) with Cu~Kα~ radiation (λ=1.54178 Å), in the range of 20° to 65° at a scan speed of 6°/min. For FESEM observation, the white powder was sprayed onto carbon tape and coated with osmium tetroxide for 5 seconds. The sample was analyzed at room temperature. For more clarification related to crystalline characterization, including morphology of the grown ZNPs, the sample was further analyzed with transmission electron microscopy (TEM) equipped with high resolution (HR-TEM). For TEM measurement, nanostructures of white ZNP powder was sonicated in ethanol for 10--15 minutes; then, a carbon-coated copper grid (400 mesh) was dipped in the suspension solution of nanoparticles and dried at room temperature, and the crystallinity and structural morphology were analyzed at 200 kV.

Animals
-------

Twenty-four male C57BL/6 mice, weighing 25--30 g and aged 9--11 weeks, were obtained from the animal facilities of King Saud University, Riyadh, Saudi Arabia. The mice were fed a standard diet and water ad libitum. The experiments were approved by state authorities and followed Saudi Arabian rules for animal protection.

Infection of mice
-----------------

To prepare the sporulated oocysts for the infection of the experimental mice, fecal pellets passed by infected mice were suspended in 2.5% (wt/vol) potassium dichromate and diluted in saturated sodium chloride for oocyst flotation. Oocysts were counted in a McMaster chamber and expressed as number of oocysts per gram of wet feces.[@b10-ijn-10-1961]

Animals were divided into three groups, with eight mice per group. The first group was the noninfected, control group, which was gavaged with 100 μL of distilled water. The second and the third groups were orally inoculated with 1,000 sporulated oocysts of *E. papillata* suspended in 100 μL distilled water. The third group also received an oral dose of 10 mg/Kg ZNPs suspended in 100 μL distilled water daily for 5 consecutive days. The dose was chosen according to Alkaladi et al[@b11-ijn-10-1961] Powdered ZNPs were suspended in Milli-Q^®^ water and were sonicated for 15 minutes at 40 W, using a sonicator (Pro Scientific, Oxford, CT, USA), to form an homogeneous suspension before the treatments.

Histopathology of the jejunum
-----------------------------

Mice jejuna were freshly prepared and fixed in 10% neutral buffered formalin for 24 hours at room temperature. Specimens were then routinely dehydrated with ethanol and then, embedded in paraffin. After this, 5 μm sections of the paraffin were stained with hematoxylin and eosin according to the method described by Drury and Wallington.[@b12-ijn-10-1961] These tissue sections were then scored for inflammatory lesions (infiltrations by mononuclear cells, neutrophils, eosinophils, and plasmacytes), for fibrin exudation and lymphangiectasis, for tissue destruction (enterocyte loss, ballooning degeneration, edema, and mucosal atrophy), and for tissue repair (hyperplasia, angiogenesis, granulomas, and fibrosis), according to the criteria established by Dommels et al.[@b13-ijn-10-1961] A rating score between 0 (no change from normal tissue) and 3 (involved most areas and all the layers of the intestinal section, including mucosa, muscle, and omental fat) was given for each aspect of inflammatory lesion, tissue destruction, and tissue repair. The sum of the inflammatory lesions, tissue destruction, and tissue repair scores was used to represent the total histological injury score for each section. In addition, the sum of the inflammatory lesions was multiplied by 2 to give more weight to this value where the tissue changes were mainly characterized by inflammatory lesions.[@b13-ijn-10-1961]

Number of goblet cells
----------------------

Sections were stained with Alcian blue for the identification of goblet cells. For each animal, the number of goblet cells in the jejunum was counted on at least ten well-oriented crypt-villous units (VCUs). Results were expressed as the mean number of goblet cells per ten VCUs.[@b14-ijn-10-1961] The number of parasitic infections in ten VCUs (mainly found within the crypt) was counted.

Biochemical analysis
--------------------

Mice jejuna from all the groups were weighed and immediately homogenized to give 50% (w/v) homogenate, in an ice-cold medium containing 50 mM tris(hydroxymethyl) aminomethane (Tris)-HCl and 300 mM sucrose.[@b15-ijn-10-1961] The homogenate was centrifuged at 500× *g* for 10 minutes, at 4°C. The supernatant (10%) was used for the various biochemical determinations.

Glutathione (GSH)
-----------------

GSH was determined chemically in the jejunum homogenate using Ellman's reagent (5,5′ dithiobis (2-nitrobenzoic acid)).[@b16-ijn-10-1961] The method is based on the reduction of Ellman's reagent with GSH to produce a yellow compound. The chromogen is directly proportional to the GSH concentration, and its absorbance was measured at 405 nm.

Malondialdehyde (MDA)
---------------------

Lipid peroxidation in plasma and jejunum homogenate was determined according to the method of Ohkawa et al[@b17-ijn-10-1961] by using 1 mL of trichloroacetic acid 10% and 1 mL of thiobarbituric acid 0.67%, followed by heating in a boiling water bath for 30 minutes. Thiobarbituric acid-reactive substances were determined by the absorbance at 535 nm and expressed as MDA equivalents formed.

Nitric oxide
------------

The assay of nitric oxide in plasma and jejunum homogenate was done according to the method of Berkels et al.[@b18-ijn-10-1961] In an acid medium and in the presence of nitrite, the formed nitrous acid diazotizes sulfanilamide, which is coupled with *N*-(1-naphthyl) ethylenediamine. The resulting azo dye has a bright reddish-purple color, which was measured at 540 nm.

Statistical analysis
--------------------

One-way ANOVA was carried out, and statistical comparisons between the groups were performed with Duncan's test, using a statistical package program (SPSS version 17.0). All *P*-values were two-tailed, and *P*\<0.05 was considered as significant for all the statistical analyses in this study.

Results
=======

[Figure 1](#f1-ijn-10-1961){ref-type="fig"} shows ZNPs at a low magnification ([Figure 1A](#f1-ijn-10-1961){ref-type="fig"}); the spherical structure in the image was formed by the assortment of several tiny NPs. The image also shows that the particles aggregated, with several particles being joined together in a clump formation. The image further indicates that the estimated diameter of each individual spherical nanoparticle was very small (\~15--20 nm), and that they had a smooth and clear morphology ([Figure 1B](#f1-ijn-10-1961){ref-type="fig"}). To further clarify the structural morphology of the grown nanoparticles, the nanostructures were reanalyzed at a higher magnification. This confirmed that the diameter of each NP was in the range of \~15--20 nm ([Figure 1C](#f1-ijn-10-1961){ref-type="fig"}).

The size and shapes of the grown nanoparticles observed using FESEM analysis ([Figure 1A--C](#f1-ijn-10-1961){ref-type="fig"}) conformed closely to the XRD pattern ([Figure 1D](#f1-ijn-10-1961){ref-type="fig"}). The crystalline property of the grown material was analyzed with XRD. The obtained diffraction peaks, such as \<1010, \<0002, \<1011, \<1012, \<1120, and \<1013 were well-matched with the lattice constants of zinc oxide a =3.249 and c =5.206 Å ([Figure 1D](#f1-ijn-10-1961){ref-type="fig"}). The data matches well with the standard data issued by the Joint Committee on Powder Diffraction Standards (JCPDS 36-1451). In the XRD spectrum, no other peak was observed except for zinc oxide. The particle size of the ZNPs was calculated with the well-known Scherer formula,[@b19-ijn-10-1961] with full width at half maximum (FWHM) of XRD pattern, and the value of the peak position was as tabulated ([Table S1](#SD2-ijn-10-1961){ref-type="supplementary-material"}), according to the formula: $$D = \frac{0.9\lambda}{\beta\cos\theta},$$where λ is the wavelength of the X-ray radiation source; β is FWHM, in radians; and θ is Bragg's diffraction angle. The calculation was measured with the help of a Gaussian Lorentzian fitting program ([Table S1](#SD2-ijn-10-1961){ref-type="supplementary-material"}). The average value of particle sizes was \~13 nm. The size of the grown ZNPs observed from FESEM analysis was consistent with the XRD ([Figure 1D](#f1-ijn-10-1961){ref-type="fig"}) pattern.

The structural morphology and crystallinity of the grown ZNPs was further confirmed via HR-TEM. [Figure 1E](#f1-ijn-10-1961){ref-type="fig"} show the TEM image at low magnification, whereas [Figure 1F](#f1-ijn-10-1961){ref-type="fig"} illustrates the HR-TEM image of ZNP powder. From the image, it is clear that several spherically shaped ZNPs could be seen at low magnification ([Figure 1E](#f1-ijn-10-1961){ref-type="fig"}). The size of each nanoparticle was in the range of 10--15 nm and had a smooth surface, spherical shape, which is clearly consisted with the observed data of the FESEM images. The crystalline character of the grown nanostructures was observed with HR-TEM ([Figure 1B and C](#f1-ijn-10-1961){ref-type="fig"}) and showed the lattice fringe variance between two adjacent planes was about 0.265 nm, which is closely analogous to commercial wurtzite zinc oxide.[@b20-ijn-10-1961]--[@b22-ijn-10-1961] It is evident from the low-magnification TEM and HR-TEM images ([Figure 1E and F](#f1-ijn-10-1961){ref-type="fig"}) that the grown ZNPs were monocrystalline in nature.

Infection of mice with *E. papillata* sporulated oocysts led to the shedding of nonsporulated oocysts in the mice feces. On day 5 postinnoculation, the oocyst output was approximately 30×10^3^ oocysts/g feces ([Figure 1](#f1-ijn-10-1961){ref-type="fig"}). The presence of ZNPs, meanwhile, was associated with a significant decrease in the oocyst output, by about 50% ([Figure 2](#f2-ijn-10-1961){ref-type="fig"}).

Through examination of the hematoxylin--eosin sections, it was clear that *E. papillata* induced remarkable histopathological changes in the infected jejunum. In addition, many developmental stages of the parasite were prominent in the jejuna villi ([Figure 3](#f3-ijn-10-1961){ref-type="fig"}). [Figure 4](#f4-ijn-10-1961){ref-type="fig"} shows that the infected mice appeared to have moderate inflammatory injury, which accords with the work of Dommels et al.[@b13-ijn-10-1961] This injury was diminished when mice were treated with ZNPs. Also, the *E. papillata*-infected mice jejuna appeared to contain a smaller number of developmental stages when treated with ZNPs ([Figures 3](#f3-ijn-10-1961){ref-type="fig"} and [4](#f4-ijn-10-1961){ref-type="fig"}).

Alcian blue-stained sections showed goblet cells as blue-stained ([Figure S1](#SD1-ijn-10-1961){ref-type="supplementary-material"}). On day 5 PI with *E. papillata*, the number of goblet cells was significantly decreased when compared with the control noninfected mice ([Figure 5](#f5-ijn-10-1961){ref-type="fig"}). ZNPs, however, were associated with the restoration of the number of goblet cells ([Figure 5](#f5-ijn-10-1961){ref-type="fig"}).

Infection of mice with *E. papillata* caused a significant decrease in the level of jejuna GSH ([Table 1](#t1-ijn-10-1961){ref-type="table"}). Treatment of mice with ZNPs, however, was able to increase the level of GSH significantly when compared with both the noninfected and infected mice ([Table 1](#t1-ijn-10-1961){ref-type="table"}). Furthermore, the infection induced a significant increase in the level of both nitric oxide and MDA ([Table 1](#t1-ijn-10-1961){ref-type="table"}), but treatment with ZNPs improved both these parameters ([Table 1](#t1-ijn-10-1961){ref-type="table"}).

Discussion
==========

Zinc supplementation has been successfully used as a therapeutic and preventive agent for many conditions.[@b23-ijn-10-1961] Here, we have showed that ZNPs exhibit anticoccidial activity, evidenced as a significant lowering in the output of *E. papillata* oocysts within the feces of infected mice. This diminished output reflects that ZNPs impaired the development of parasites in the host before the relatively inert oocysts could be formed and finally released. The fact that ZNPs possess anticoccidial activity has not been reported before, but Bafundo et al[@b24-ijn-10-1961] demonstrated clearly that zinc utilization is diminished by *Eimeria acervulina* infection.

The results of both biochemical and histological investigations further showed that while infection with *E. papillata* induced a marked injury of the jejunum through induction of oxidative stress, the administration of ZNPs helped to protect against these negative effects. It has previously been shown that *E. papillata* infections cause an inflammatory response in the jejunum of mice[@b25-ijn-10-1961] and that this response manifests itself as a perturbed jejunum structure and as a significant increase in nitric oxide and MDA levels. Zinc, meanwhile, has previously been used in the treatment of gastrointestinal inflammatory disorders,[@b26-ijn-10-1961] and ZNPs are known to be able to prevent the loss of GSH during oxidative damage induced by infection, as has been described by Dkhil et al.[@b27-ijn-10-1961] It is postulated that the active oxygen species generated by these metal oxide particles could be the main mechanism of their antibacterial activity.[@b7-ijn-10-1961] More generally, it is recognized that dietary trace elements/antioxidants can help maintain an appropriate antioxidant balance in the case of many infections.[@b28-ijn-10-1961] Wunderlich et al[@b4-ijn-10-1961] for example, reported that zinc is fundamentally important for a balanced redox state, for the immune system, as well as for growth and development. More recently, Shoae-Hagh et al[@b29-ijn-10-1961] reported that ZNPs reduce apoptosis and oxidative stress values in isolated rat pancreatic islets.

Goblet cells are the major intestinal immunocompetent cells where they secrete mucous.[@b30-ijn-10-1961] The depletion of goblet cells was most evident in the infected jejuna villi, but there was no evidence of *E. papillata* infection within the goblet cells themselves. The decrease in the number of goblet cells induced by infection may be due to the damage caused by the parasite to the stem cells that produce goblet cells, which are present in the intestinal crypts.[@b31-ijn-10-1961] Yunus et al[@b32-ijn-10-1961] reported that changes in goblet cell numbers may affect the susceptibility of the parasite-infected host to limit the capacity of opportunistic pathogens from increasing or penetrating the local epithelium. Zinc supplementation significantly increased villus goblet cell numbers,[@b33-ijn-10-1961] and this increase in goblet cells seen in the group treated with ZNPs may be indicative of improved innate responses to *E. papillata* infection.

Conclusion
==========

In summary, we successfully prepared ZNPs, and the crystalline character, structure, phase, and morphology of the synthesized product were investigated. Our data also indicated that ZNPs exhibited anticoccidial and antioxidant properties, and it is proposed that they could be used as a feed additive, with minimal processing.

Supplementary materials
=======================

###### 

Goblet cells in mouse jejuna. Section from noninfected control mice (**A**), from *Eimeria papillata*--infected mice (**B**), and from infected ZNP-treated mice (**C**).

**Notes:** Sections were stained with Alcian blue. Bar =50 μm.

**Abbreviation:** ZNP, zinc oxide nanoparticle.

###### 

Calculation of particle size of ZNPs from FWHM of X-ray diffraction pattern

         Phase    Peak position   FWHM (radians)   Cos Bragg's angle θ   Particle size (nm)
  ------ -------- --------------- ---------------- --------------------- --------------------
  ZNPs   1010     31.67°          0.010543         0.96205               13.668
  0002   34.33°   0.009201        0.95545          15.766                
  1011   36.16°   0.010875        0.95062          13.406                
  1012   47.46°   0.012688        0.91543          11.932                
  1120   56.52°   0.014268        0.88080          11.028                
  1013   62.80°   0.015158        0.85355          10.712                

**Abbreviations:** FWHM, full width at half maximum; ZNP, zinc oxide nanoparticle.
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![TEM images and X-ray diffraction pattern of ZNPs. (**A**--**C**), TEM images of ZNPs with different magnifications. (**D**) X-ray diffraction pattern of ZNPs. (**E**) The low-magnification TEM image of ZNPs and their corresponding HR-TEM image, which presents (**F**) the lattice variance between two fringes, about \~0.265 nm.\
**Abbreviations:** HR-TEM, high-resolution transmission electron microscopy; TEM, transmission electron microscopy; ZNP, zinc oxide nanoparticle.](ijn-10-1961Fig1){#f1-ijn-10-1961}

![Oocyst output of mice 5 days after having been infected with 1,000 sporulated *Eimeria papillata* oocysts.\
**Notes:** All values are expressed as mean ± SD. \*Significant change between infected ZNPs treated and untreated groups (*P*≤0.05), n=8.\
**Abbreviations:** SD, standard deviation; ZNP, zinc oxide nanoparticle.](ijn-10-1961Fig2){#f2-ijn-10-1961}

![Effect of ZNPs on *Eimeria papillata*-induced jejunum injury on day 5. (**A**) Noninfected jejunum with normal architecture of the absorptive epithelium and lamina propria. (**B**) Infected jejunum with some pathological changes in lamina propria and absorptive epithelia. Developmental stages appearing in the absorptive epithelia. (**C**) Infected treated mouse exhibiting fewer parasites.\
**Notes:** Sections are stained with hematoxylin and eosin. Bar =25 μm.\
**Abbreviation:** ZNP, zinc oxide nanoparticle.](ijn-10-1961Fig3){#f3-ijn-10-1961}

![ZNP induced changes in the total histological injury score in jejunum of noninfected and *Eimeria papillata*-infected mice.\
**Notes:** Scores were calculated according to Dommels et al.[@b13-ijn-10-1961] Values are expressed as mean ± SD. ^a^Significant in respect to the noninfected (− ZNP) group (*P*≤0.05); ^b^significant in respect to the infected (− ZNP) group (*P*≤0.05).\
**Abbreviations:** SD, standard deviation; ZNP, zinc oxide nanoparticle.](ijn-10-1961Fig4){#f4-ijn-10-1961}

![ZNP induced changes in the number of goblet cells in the jejunum of noninfected mice and mice infected with *Eimeria papillata* on day 5 postinnoculation.\
**Notes:** Data were obtained from Alcian blue-stained sections. Values are expressed as mean ± SD. ^a^Significant in respect to the noninfected (− ZNP) group (*P*≤0.05); ^b^significant in respect to the infected (− ZNP) group (*P*≤0.05).\
**Abbreviations:** SD, standard deviation; CVU, crypt-villus unit; ZNP, zinc oxide nanoparticle.](ijn-10-1961Fig5){#f5-ijn-10-1961}

###### 

Zinc oxide nanoparticles ameliorates *E*. *papillata* induced changes in the level of jejunal glutathione, nitric oxide, and malondialdehyde

  Group                 Glutathione (mg/g)                                                                                 Nitric oxide (μm/g)                                                                                Malondialdehyde (nm/g)
  --------------------- -------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------
  Noninfected (− ZNP)   85±2.3                                                                                             65±2.2                                                                                             15±1
  Infected (− ZNP)      49.36±1.8[a](#tfn2-ijn-10-1961){ref-type="table-fn"}                                               81.60±2.6[a](#tfn2-ijn-10-1961){ref-type="table-fn"}                                               21.34±1.4[a](#tfn2-ijn-10-1961){ref-type="table-fn"}
  Infected (+ ZNP)      100.8±2.9[a](#tfn2-ijn-10-1961){ref-type="table-fn"},[b](#tfn3-ijn-10-1961){ref-type="table-fn"}   41.14±2.4[a](#tfn2-ijn-10-1961){ref-type="table-fn"},[b](#tfn3-ijn-10-1961){ref-type="table-fn"}   11.05±0.4[a](#tfn2-ijn-10-1961){ref-type="table-fn"},[b](#tfn3-ijn-10-1961){ref-type="table-fn"}

**Notes:** Values are expressed as mean ± SD.

*P*≤0.05, significant against non-infected (− ZNP) group;

*P*≤0.05, significant against infected (− ZNP) group.

**Abbreviations:** ZNP, zinc oxide nanoparticle; SD, standard deviation.
